HighMark Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
HighMark Wealth Management's GILD Position: Q3 2026 in Review
HighMark Wealth Management increased its Gilead Sciences (GILD) stake by 34% in Q3 2026, buying an estimated $10.4K and bringing the position to 291 shares worth $43.7K. The position accounts for 0.01% of the portfolio, ranked #176.
HighMark Wealth Management first reported a position in GILD in Q4 2019 and has held it in 28 quarters since. 2,347 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- HighMark Wealth Management held 291 shares of Gilead Sciences worth $43.7K as of Q3 2026.
- HighMark Wealth Management bought 74 Gilead Sciences shares in Q3 2026, an estimated $10.4K.
- Gilead Sciences made up 0.01% of HighMark Wealth Management's portfolio in Q3 2026, its #176 holding.
- HighMark Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 28 quarters since.
- 2,347 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on HighMark Wealth Management's 13F filing for Q3 2026, filed 17 Nov 2026.